EVE
EVE HEALTH GROUP LIMITED.
$0.0110
▼ -15.38%
Market cap
$4M
Turnover
$36,857
Last price
$0.0110
Day change
-15.38%
Announcements
8
Range, past year
Open 0.026 · Low 0.001 · Now 0.011 · High 0.036
Open EVE in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
EVE momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-11-16.
Momentum quality
33/100
Wyckoff phase
Accumulation5d
Trend stage
Neutral
1 Day
-15.4%
1 Week
-8.3%
1 Month
-26.7%
1 Year
-60.7%
RSI
38
Avg daily range
10.2%
EVE HEALTH GROUP LIMITED. scores 33 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Neutral.
On the Wyckoff cycle it sits in Accumulation, where it has been for 5 trading days. The weekly timeframe reads Downtrend, which does not yet agree with the daily view.
Against the wider market it is currently underperforming and the institutional accumulation signal reads moderate.
What stands out
- Volume 2.3× 60-day avg
Points to watch
- 60d drawdown -38.9%
- High volatility (ATR 10.2%)
- Thin liquidity
- Risk rating: Very High
- Composite downside risk elevated
EVE announcements
Recent price-sensitive releases.
- 2026-11-10 Australian Compounding Agreement Signed for Men's Health Progress Report
- 2026-10-30 Quarterly Activities/Appendix 4C Cash Flow Report Commitments Test Entity - First Quarter Activity Report | Commitments Test Entity - First Quarter Cashflow Report
- 2026-08-31 Appendix 4E Preliminary Final Report
- 2026-08-07 Quarterly Activities/Appendix 4C Cash Flow Report - Amended Commitments Test Entity - Fourth Quarter Activity Report | Commitments Test Entity - Fourth Quarter Cashflow Report
- 2026-07-31 Quarterly Activities/Appendix 4C Cash Flow Report Commitments Test Entity - Fourth Quarter Activity Report | Commitments Test Entity - Fourth Quarter Cashflow Report
- 2026-06-16 Eve Initiates Pilot Clinical Study for Libbo ED Film
- 2026-04-29 Quarterly Activities/Appendix 4C Cash Flow Report
More Consumer Staples stocks
Most traded in the same sector.